GUTS (STOCKS)
Fractyl Health, Inc. Common Stock
$0.463500
+0.003500 (+0.76%)
Prev close: $0.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harith Rajagopalan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $76.52M
- Employees
- 109
- P/E (TTM)
- -0.24
- P/B (TTM)
- 7.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.07 | $-0.18 | +0.1136 | +61.87% |
|
Sep 2025 (Q3)
|
$-0.71 | $-0.32 | -0.3877 | -120.29% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.37 | -0.2028 | -55.23% |
|
Mar 2025 (Q1)
|
$-0.49 | $-0.49 | -0.0038 | -0.78% |
Financial Statements
| Revenues | $0.00 |
| Cost Of Revenue | $0.00 |
| Nonoperating Income/Loss | -$44.14M |
| Operating Expenses | $96.82M |
| Selling, General, and Administrative Expenses | $22.28M |
| Research and Development | $74.54M |
| Operating Income/Loss | -$96.82M |
| Income/Loss From Continuing Operations After Tax | -$140.95M |
| Income/Loss From Continuing Operations Before Tax | -$140.95M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$140.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$140.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$140.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.86 |
| Diluted Earnings Per Share | -$1.86 |
| Basic Average Shares | 75,819,960 |
| Diluted Average Shares | 75,819,960 |
| Assets | $121.40M |
| Current Assets | $87.58M |
| Noncurrent Assets | $33.83M |
| Fixed Assets | $2.41M |
| Other Non-current Assets | $31.42M |
| Liabilities | $111.94M |
| Current Liabilities | $18.33M |
| Accounts Payable | $1.57M |
| Other Current Liabilities | $16.76M |
| Noncurrent Liabilities | $93.62M |
| Equity | $9.46M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.46M |
| Liabilities And Equity | $121.40M |
| Net Cash Flow From Operating Activities | -$90.33M |
| Net Cash Flow From Operating Activities, Continuing | -$90.33M |
| Net Cash Flow From Investing Activities | -$557.00K |
| Net Cash Flow From Investing Activities, Continuing | -$557.00K |
| Net Cash Flow From Financing Activities | $104.96M |
| Net Cash Flow From Financing Activities, Continuing | $104.96M |
| Net Cash Flow | $14.08M |
| Net Cash Flow, Continuing | $14.08M |
| Comprehensive Income/Loss | -$140.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$140.95M |
| Other Comprehensive Income/Loss | $0.00 |